Benefits Include:

  • Available on more than 95% of managed care plans with formulary coverage comparable to insulin glargine2* Learn more
  • For use in combination with metformin + Victoza® (liraglutide [rDNA origin] injection) in adult patients with type 2 diabetes1 Learn more
  • First FDA-approved basal insulin analog with Pregnancy Category B1 Learn more
  • The first basal insulin analog approved for use in children as young as 2 years of age with type 1 diabetes1 Learn more
  • A1C and FPG reductions at a once-daily dose in patients with type 2 diabetes.1,3 Learn more
  • Low rate of hypoglycemia in patients with type 2 diabetes1,3 Learn more
  • Consistent action with no pronounced peak1,4 Learn more
  • Less weight gain vs insulin glargine5,6 Learn more
  • Levemir® FlexPen® lasts a maximum of 42 days unrefrigerated1† Learn more

* Intended as a guide. Lower acquisition costs alone do not necessarily reflect a cost advantage in the outcome of the condition treated because there are other variables that affect relative costs. Formulary status is subject to change.

Must be kept at room temperature, below 86°F (30°C) once in use. Discard Levemir® FlexPen® (opened or unopened) 42 days after it is taken out of the refrigerator.